Roses and co-workers showed that although high nuclear grade, large lesion size, and HER2 overexpression in ductal carcinoma in situ (DCIS) were associated with invasive disease on univariate analysis, HER2 is the only significant predictor for the presence of invasive breast cancer. Here, ERBB2 is linked to invasive breast carcinoma.